OMI - Owens & Minor, Inc.
NYSE
->
Healthcare
->
Medical Distribution
Mechanicsville,
United States
Type: Equity
OMI price evolution
OMI
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $243.67 | $244.87 | $243.04 | |
| Short term investments | ||||
| Net receivables | $661.66 | $662.44 | $669.86 | $598.26 |
| Inventory | $1242.45 | $1231.41 | $1144.6 | $1110.61 |
| Total current assets | $2116.54 | $2327.07 | $2236.34 | $2102.79 |
| Long term investments | ||||
| Property, plant & equipment | $856.01 | $861.55 | $851.37 | $840.5 |
| Goodwill & intangible assets | $1960.9 | $1977.96 | $2000.68 | |
| Total noncurrent assets | $2976.93 | $2971.65 | $2990.53 | |
| Total investments | ||||
| Total assets | $5081.28 | $5304 | $5207.99 | $5093.32 |
| Current liabilities | ||||
| Accounts payable | $1338.02 | $1381.87 | $1218.82 | $1171.88 |
| Deferred revenue | ||||
| Short long term debt | $210.91 | $207.66 | $206.9 | |
| Total current liabilities | $1934.17 | $2131.18 | $1933.09 | $1891.88 |
| Long term debt | $1842.35 | $2169.53 | $2222.33 | $2113.03 |
| Total noncurrent liabilities | $2312.12 | $2380.03 | $2277.27 | |
| Total debt | $2380.44 | $2429.99 | $2319.93 | |
| Total liabilities | $4206.69 | $4443.3 | $4313.13 | $4169.16 |
| Shareholders' equity | ||||
| Retained earnings | $302.14 | $314.91 | $346.82 | $368.71 |
| Other shareholder equity | -$27.42 | -$48.74 | -$43.44 | -$31.82 |
| Total shareholder equity | $860.7 | $894.87 | $924.17 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $243.04 | $69.47 | $55.71 | $83.06 |
| Short term investments | ||||
| Net receivables | $598.26 | $763.5 | $681.56 | $700.79 |
| Inventory | $1110.61 | $1333.59 | $1495.97 | $1233.75 |
| Total current assets | $2102.79 | $2295.18 | $2321.81 | $2135.86 |
| Long term investments | ||||
| Property, plant & equipment | $840.5 | $858.93 | $511.24 | $460.42 |
| Goodwill & intangible assets | $2000.68 | $2081.75 | $599.93 | $637.44 |
| Total noncurrent assets | $2990.53 | $3091.1 | $1214.74 | $1199.77 |
| Total investments | ||||
| Total assets | $5093.32 | $5386.28 | $3536.55 | $3335.64 |
| Current liabilities | ||||
| Accounts payable | $1171.88 | $1147.41 | $1001.96 | $1000.19 |
| Deferred revenue | ||||
| Short long term debt | $206.9 | |||
| Total current liabilities | $1891.88 | $1566.47 | $1344.02 | $1345.73 |
| Long term debt | $2113.03 | $2482.97 | $1109.78 | $1105.95 |
| Total noncurrent liabilities | $2277.27 | $2874.21 | $1254.03 | $1277.86 |
| Total debt | $2319.93 | $2698.44 | $1109.78 | $1105.95 |
| Total liabilities | $4169.16 | $4440.68 | $2598.05 | $2623.59 |
| Shareholders' equity | ||||
| Retained earnings | $368.71 | $410.01 | $387.62 | $167.02 |
| Other shareholder equity | -$31.82 | -$35.85 | -$40.59 | -$38.51 |
| Total shareholder equity | $924.17 | $945.6 | $938.5 | $712.05 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2721.13 | $2671.01 | $2612.68 | $2656.15 |
| Cost of revenue | $2126.85 | $2077.15 | $2086.23 | |
| Gross Profit | $559.71 | $544.15 | $535.53 | $569.92 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $469.31 | $477.61 | $457.23 | |
| Total operating expenses | $500.12 | $523.85 | $498.48 | $509.9 |
| Operating income | $20.3 | $37.05 | $60.02 | |
| Income from continuing operations | ||||
| EBIT | $19.09 | $8.54 | $57.86 | |
| Income tax expense | -$1.02 | $15.11 | -$5.23 | $3.21 |
| Interest expense | -$36.55 | $35.9 | $35.66 | $36.86 |
| Net income | ||||
| Net income | -$12.77 | -$31.91 | -$21.89 | $17.78 |
| Income (for common shares) | -$31.91 | -$21.89 | $17.78 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $10333.97 | $9955.48 | $9785.32 | $8480.18 |
| Cost of revenue | $8208.81 | $8129.12 | $8272.09 | $7199.34 |
| Gross Profit | $2125.16 | $1826.35 | $1513.23 | $1280.83 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1813.56 | $1633.67 | $1116.87 | $1041.34 |
| Total operating expenses | $2020.65 | $1683.44 | $1144.76 | $1076.72 |
| Operating income | $104.51 | $142.91 | $368.47 | $204.12 |
| Income from continuing operations | ||||
| EBIT | $103.19 | $139.78 | $324.84 | $135.1 |
| Income tax expense | -$13.43 | -$11.5 | $55.16 | $21.83 |
| Interest expense | $157.91 | $128.89 | $48.09 | $83.4 |
| Net income | ||||
| Net income | -$41.3 | $22.39 | $221.59 | $29.87 |
| Income (for common shares) | -$41.3 | $22.39 | $221.59 | $29.87 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$31.91 | -$21.89 | $17.78 | |
| Operating activities | ||||
| Depreciation | $63.88 | $74.09 | $70.74 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $6.74 | $6.87 | $5.8 | |
| Total cash flows from operations | $116.15 | -$52.96 | $111.77 | |
| Investing activities | ||||
| Capital expenditures | -$28.31 | $0.13 | -$38.4 | |
| Investments | ||||
| Total cash flows from investing | -$64.23 | -$35.17 | -$1.87 | -$38.91 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | -$73.45 | $61.08 | -$50.5 | |
| Total cash flows from financing | -$224.51 | -$78.24 | $53.32 | -$51.22 |
| Effect of exchange rate | $0.41 | -$0.06 | -$0.62 | $1.13 |
| Change in cash and equivalents | -$197.83 | $2.67 | -$2.13 | $22.76 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$41.3 | $22.39 | $221.59 | $29.87 |
| Operating activities | ||||
| Depreciation | $287.38 | $228.67 | $90.62 | $93.34 |
| Business acquisitions & disposals | -$1684.61 | $133 | ||
| Stock-based compensation | $23.22 | $20.99 | $25.02 | $20.01 |
| Total cash flows from operations | $740.71 | $325.01 | $124.18 | $339.22 |
| Investing activities | ||||
| Capital expenditures | -$136.32 | -$118.2 | -$49.69 | -$58.96 |
| Investments | ||||
| Total cash flows from investing | -$137.25 | -$1804.48 | -$53.63 | $80.07 |
| Financing activities | ||||
| Dividends paid | -$0.73 | -$0.65 | ||
| Sale and purchase of stock | $189.97 | |||
| Net borrowings | -$416.69 | $1582.5 | -$81.44 | -$541.85 |
| Total cash flows from financing | -$417.33 | $1497.11 | -$129.48 | -$379.39 |
| Effect of exchange rate | $0.61 | -$3.48 | -$3.54 | $9.91 |
| Change in cash and equivalents | $186.74 | $14.15 | -$62.47 | $49.82 |
News
Fundamentals
| Market cap | $409.20M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 77.06M |
| Revenue | $10.66B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$48.78M |
| Revenue Q/Q | 4.99% |
| Revenue Y/Y | 4.22% |
| P/E ratio | -8.39 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.04 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$0.63 |
|---|---|
| ROA | -0.94% |
| ROE | N/A |
| Debt/Equity | 4.51 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.09 |
| Quick ratio | 0.45 |